ACE and heart failure: Pharmacological interventions that may delay or reverse the process of cardiac remodeling, such as angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor–neprilysin inhibitors, β-blockers, and mineralocorticoid receptor antagonists, have been effective in reducing mortality rates in individuals with heart failure [4,5,6,7].